Global Polio Vaccine Competitive Landscape Professional Research Report 2025
Description
Global Polio Vaccine Competitive Landscape Professional Research Report 2025
Research Summary
The polio vaccine is a preventive immunization designed to protect individuals from poliomyelitis, a highly contagious viral disease caused by the poliovirus. There are two primary types of polio vaccines: the inactivated polio vaccine (IPV) and the oral polio vaccine (OPV). IPV, administered as injections, contains inactivated, or killed, poliovirus strains and is commonly used in many countries. OPV, administered orally, contains weakened live poliovirus strains and has been instrumental in global polio eradication efforts due to its ability to provide intestinal immunity. These vaccines stimulate the immune system to produce antibodies, conferring immunity against polio. Vaccination campaigns, supported by organizations like the World Health Organization (WHO), have significantly reduced polio cases worldwide, bringing several regions close to eradication. The global effort to eradicate polio involves extensive vaccination programs, surveillance, and public health initiatives.
According to DIResearch's in-depth investigation and research, the global Polio Vaccine market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Polio Vaccine include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Polio Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Polio Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Polio Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Polio Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Polio Vaccine Include:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Polio Vaccine Product Segment Include:
Portable Police Law Enforcement Recorder
Hand-hold Police Law Enforcement Recorder
Polio Vaccine Product Application Include:
Infants
Child
Aldult
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Polio Vaccine Industry PESTEL Analysis
Chapter 3: Global Polio Vaccine Industry Porter’s Five Forces Analysis
Chapter 4: Global Polio Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Polio Vaccine Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Polio Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Polio Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Polio Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Polio Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Polio Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Polio Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Polio Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Polio Vaccine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Polio Vaccine Product by Type
- 1.2.1 Portable Police Law Enforcement Recorder
- 1.2.2 Hand-hold Police Law Enforcement Recorder
- 1.3 Polio Vaccine Product by Application
- 1.3.1 Infants
- 1.3.2 Child
- 1.3.3 Aldult
- 1.4 Global Polio Vaccine Market Revenue and Sales Analysis
- 1.4.1 Global Polio Vaccine Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Polio Vaccine Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Polio Vaccine Market Sales Price Trend Analysis (2020-2032)
- 1.5 Polio Vaccine Industry Trends and Innovation
- 1.5.1 Polio Vaccine Industry Trends and Innovation
- 1.5.2 Polio Vaccine Market Drivers and Challenges
- 2 Polio Vaccine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Polio Vaccine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Polio Vaccine Market Analysis by Regions
- 4.1 Polio Vaccine Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Polio Vaccine Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Polio Vaccine Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Polio Vaccine Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Polio Vaccine Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Polio Vaccine Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Polio Vaccine Sales Forecast by Region (2026-2032)
- 4.4 Global Polio Vaccine Sales Price Trend Analysis (2020-2032)
- 5 Global Polio Vaccine Market Size by Type and Application
- 5.1 Global Polio Vaccine Market Size by Type
- 5.1.1 Global Polio Vaccine Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Polio Vaccine Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Polio Vaccine Market Size by Application
- 5.2.1 Global Polio Vaccine Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Polio Vaccine Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Polio Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Polio Vaccine Market Size by Type
- 6.3.1 North America Polio Vaccine Sales by Type (2020-2032)
- 6.3.2 North America Polio Vaccine Revenue by Type (2020-2032)
- 6.4 North America Polio Vaccine Market Size by Application
- 6.4.1 North America Polio Vaccine Sales by Application (2020-2032)
- 6.4.2 North America Polio Vaccine Revenue by Application (2020-2032)
- 6.5 North America Polio Vaccine Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Polio Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Polio Vaccine Market Size by Type
- 7.3.1 Europe Polio Vaccine Sales by Type (2020-2032)
- 7.3.2 Europe Polio Vaccine Revenue by Type (2020-2032)
- 7.4 Europe Polio Vaccine Market Size by Application
- 7.4.1 Europe Polio Vaccine Sales by Application (2020-2032)
- 7.4.2 Europe Polio Vaccine Revenue by Application (2020-2032)
- 7.5 Europe Polio Vaccine Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Polio Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Polio Vaccine Market Size by Type
- 8.3.1 China Polio Vaccine Sales by Type (2020-2032)
- 8.3.2 China Polio Vaccine Revenue by Type (2020-2032)
- 8.4 China Polio Vaccine Market Size by Application
- 8.4.1 China Polio Vaccine Sales by Application (2020-2032)
- 8.4.2 China Polio Vaccine Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Polio Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Polio Vaccine Market Size by Type
- 9.3.1 APAC (excl. China) Polio Vaccine Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Polio Vaccine Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Polio Vaccine Market Size by Application
- 9.4.1 APAC (excl. China) Polio Vaccine Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Polio Vaccine Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Polio Vaccine Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Polio Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Polio Vaccine Market Size by Type
- 10.3.1 Latin America Polio Vaccine Sales by Type (2020-2032)
- 10.3.2 Latin America Polio Vaccine Revenue by Type (2020-2032)
- 10.4 Latin America Polio Vaccine Market Size by Application
- 10.4.1 Latin America Polio Vaccine Sales by Application (2020-2032)
- 10.4.2 Latin America Polio Vaccine Revenue by Application (2020-2032)
- 10.5 Latin America Polio Vaccine Market Size by Country
- 10.6 Latin America Polio Vaccine Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Polio Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Polio Vaccine Market Size by Type
- 11.3.1 Middle East & Africa Polio Vaccine Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Polio Vaccine Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Polio Vaccine Market Size by Application
- 11.4.1 Middle East & Africa Polio Vaccine Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Polio Vaccine Revenue by Application (2020-2032)
- 11.5 Middle East Polio Vaccine Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Polio Vaccine Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Polio Vaccine Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Polio Vaccine Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Polio Vaccine Average Sales Price by Manufacturers (2021-2025)
- 12.2 Polio Vaccine Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Polio Vaccine Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Sanofi
- 13.1.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Sanofi Polio Vaccine Product Portfolio
- 13.1.3 Sanofi Polio Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 GSK
- 13.2.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 GSK Polio Vaccine Product Portfolio
- 13.2.3 GSK Polio Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Bibcol
- 13.3.1 Bibcol Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Bibcol Polio Vaccine Product Portfolio
- 13.3.3 Bibcol Polio Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Serum Institute
- 13.4.1 Serum Institute Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Serum Institute Polio Vaccine Product Portfolio
- 13.4.3 Serum Institute Polio Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Tiantan Biological
- 13.5.1 Tiantan Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Tiantan Biological Polio Vaccine Product Portfolio
- 13.5.3 Tiantan Biological Polio Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 IMBCA
- 13.6.1 IMBCA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 IMBCA Polio Vaccine Product Portfolio
- 13.6.3 IMBCA Polio Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 Panacea Biotec Ltd
- 13.7.1 Panacea Biotec Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Panacea Biotec Ltd Polio Vaccine Product Portfolio
- 13.7.3 Panacea Biotec Ltd Polio Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 Bio-Med
- 13.8.1 Bio-Med Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Bio-Med Polio Vaccine Product Portfolio
- 13.8.3 Bio-Med Polio Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 Halfkin Bio-Pharmaceuticals
- 13.9.1 Halfkin Bio-Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
- 13.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Polio Vaccine Industry Chain Analysis
- 14.2 Polio Vaccine Industry Raw Material and Suppliers Analysis
- 14.2.1 Polio Vaccine Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Polio Vaccine Typical Downstream Customers
- 14.4 Polio Vaccine Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
